Cellular Origins

We are #hiring for a Simulation Lead. We are seeking someone with deep expertise in simulation coupled with a real-world problem-solving mindset. In this role you’ll play a pivotal role in designing and developing our robotic Constellation™ system. As a key technical authority, you will help shape the strategy of our products and be involved in end-to-end development of groundbreaking solutions. Apply now to join our team, and play a crucial role in the development of an elegant, next-generation solution to transform patient access to life-saving #celltherapies: https://bit.ly/45MiVF4

Meet Nikki Phoolchund, our Reliability & Test Lead. Nikki was an early employee at CMR Surgical, where she was responsible for the design and implementation of several components for the robotic surgical arm. During her time with the Company, she helped to take the device from early concept through to testing for regulatory approval. In other roles, Nikki set up and managed testing and investigations teams, helping to support manufacturing scale-up operations. 🧗♀️🚴♂️🔨 Outside of work, Nikki enjoys running, climbing and cycling. Her passion for building and fixing things also extends into her personal life, where she is currently tackling an ongoing home renovation project. Learn more about career opportunities at Cellular Origins ➡ https://rb.gy/d8bubq

Last week, Jason Jones took part in a panel at the Women in Advanced Therapies Global event. The session, "Bridging Communication Divides: Navigating Differing Styles for Allyship and Understanding", saw panellists explore the intricacies of different communication styles, and how understanding these differences can be the key to building effective connections in an increasingly diverse world. The panel featured fascinating insights from Lindsey Clarke, Jo Harvey, Maria Waller and Sven Kili. "Inspired by the analogy that men are from Mars and Women are from Venus, the panel provided opportunities to share and reflect on our experiences with communication dynamics, both in the workplace and beyond. The depth and breadth of conversations highlighted just how intertwined these dynamics are with each of our own lived experiences, as well as societal norms. By fully embracing these differences, and acknowledging that communication strategy is not a 'one size fits all' solution, we can build more effective connections across all aspects of our lives." - Jason Jones, Global Business Development Lead, Cellular Origins. Find out more about the Women in Advanced Therapies community and their events here: https://bit.ly/4f5CRaf

We’re #hiring for a Head of Manufacturing. We are seeking a highly experienced, innovative and delivery-focused Manufacturing leader who is capable of inspiring teams to excel. In this role, you’ll join and work closely with our senior leadership team. You will drive our manufacturing efforts by providing strategic leadership and operational oversight, focusing on resource management, team development and process improvement to ensure manufacturing activities adhere to safety and compliance standards Does this sound like you? Apply to join our team, and help us lead the revolution to transform how we tackle the challenges of #celltherapy production: https://bit.ly/3L5GeAi

We've been shortlisted in this year's Business Weekly Awards! We're proud to have been recognised alongside other trailblazing companies from across #Cambridgeshire that are leading the way in #lifesciences, #tech, #engineering and more. Read the full shortlist in Business Weekly newspaper: https://bit.ly/4bA8QfK #BusinessWeeklyAwards

It’s been an incredibly exciting first 6 months of 2024 for Cellular Origins. The best thing? The growth of the exceptional team. Since we began in 2023, we’ve expanded rapidly to help drive us forward on our mission to transform patient access to life-saving #celltherapies. We're still looking for talented individuals from #engineering & other disciplines to join our team and help develop our cutting-edge robotic system, Constellation™. If you're excited about our mission, we'd love to hear from you. Express your interest here ➡ https://bit.ly/3WiMoU3

We're pleased to announce the appointment of Geoffrey Hodge as Non-Executive Director, further strengthening our Board with significant commercial, strategic and technical experience. In addition to his role on the Board, Geoff will remain part of our Scientific Advisory Board, where his extensive experience in developing biomanufacturing technology and proven commercial success has already helped to shape the Company’s strategic direction. Dr Edwin Stone speaks on the news: "Geoff has unique experience having built businesses that have transformed bioprocess manufacturing. There are very few individuals who have been through this journey. At Cellular Origins, we know how important it is to our customers that we can deliver solutions they can rely on and trust for the manufacturing of important therapies. Geoff’s expertise in building a business that was successful in doing this will be invaluable to Cellular Origins. His guidance, technical and commercial insight and industry network are, and will continue to be, a crucial asset as we realise our ambition to achieve faster, cost-effective and efficient routes to scalable manufacture of cell therapies." Read the full press release here: https://bit.ly/3LhHpMO

Did you catch our talk at #ACHEMA24? Dr Dan Strange and Dr Leo Steenson were pleased to take part in STÄUBLI Robotics 'Pharma Impulses meets ACHEMA 2024' event, a series of exciting interviews with pioneering companies that are bringing advanced #robotics and #automation into the #pharmaceutical industry. The interview provides a deep dive into Constellation™ - our cutting-edge robotic platform for scalable, affordable manufacture of #cellandgenetherapies, and discusses how we have worked closely with our partners, including the Stäubli team, to unlock the next generation of #pharma automation. Watch the interview here ➡ https://bit.ly/45xbAsM

#ACHEMA24 gave our team, together with our partner STÄUBLI Robotics, an exciting opportunity to showcase our #robotic platform for scalable manufacture of #cellandgenetherapies, Constellation™, alongside the other cutting-edge technology ensuring that #bioprocessing continues to remain at the forefront of innovation. 💬 Our CTO, Dan Strange, says: “ACHEMA was a great opportunity to get up close with an exciting array of new innovations that are pushing the boundaries of possibility within the pharmaceutical manufacturing industry. We particularly enjoyed the chance to talk more about our close partnership with the team at Stäubli, where we are using mobile robotics to transform the cell therapy manufacturing space.” If you would like to learn more about Constellation and how we can work together, please get in touch 📧 hello@cellularorigins.com

We’re pleased to announce that we have acquired ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP. The ACTIA platform allows for massively multiplex and distributed industrial automation and will accelerate and expand our R&D efforts to further develop Constellation™ - our robotic platform for #celltherapy manufacturing. Our CEO, Dr Edwin Stone, reflects: “The acquisition of the ACTIA Platform IP shows Cellular Origins continued dedication to creating the most efficient, cost effective and scalable solution to cell therapy manufacturing. Combined with ongoing R&D, this expansion of our technology and IP portfolio underpins our commitment to develop Constellation to solve the challenge of affordable, large-scale production of cell therapies that meets the needs of our customers and ensures we can offer the right solution for long-term success.” Read the full press release here: https://bit.ly/3xM2iwD